These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22078906)

  • 1. Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6.
    Shigemoto N; Kuwahara R; Kayama S; Shimizu W; Onodera M; Yokozaki M; Hisatsune J; Kato F; Ohge H; Sugai M
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):109-12. PubMed ID: 22078906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid detection of blaIMP-6 by amplification refractory mutation system.
    Kayama S; Shigemoto N; Kuwahara R; Onodera M; Yokozaki M; Ohge H; Kato F; Hisatsune J; Sugai M
    J Microbiol Methods; 2012 Jan; 88(1):182-4. PubMed ID: 22108497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meropenem resistance in imipenem-susceptible meropenem-resistant Klebsiella pneumoniae isolates not detected by rapid automated testing systems.
    Harino T; Kayama S; Kuwahara R; Kashiyama S; Shigemoto N; Onodera M; Yokozaki M; Ohge H; Sugai M
    J Clin Microbiol; 2013 Aug; 51(8):2735-8. PubMed ID: 23720796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain.
    Curiao T; Morosini MI; Ruiz-Garbajosa P; Robustillo A; Baquero F; Coque TM; Cantón R
    J Antimicrob Chemother; 2010 Aug; 65(8):1608-14. PubMed ID: 20513703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase.
    Cuzon G; Naas T; Guibert M; Nordmann P
    Int J Antimicrob Agents; 2010 Mar; 35(3):265-8. PubMed ID: 20034767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy.
    Findlay J; Hamouda A; Dancer SJ; Amyes SG
    Clin Microbiol Infect; 2012 Feb; 18(2):140-6. PubMed ID: 21745255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.
    Cubero M; Cuervo G; Dominguez MÁ; Tubau F; Martí S; Sevillano E; Gallego L; Ayats J; Peña C; Pujol M; Liñares J; Ardanuy C
    BMC Microbiol; 2015 Sep; 15():177. PubMed ID: 26335352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of blaNDM-1 among Klebsiella pneumoniae ST15 and novel ST1031 clinical isolates in China.
    Hu L; Zhong Q; Tu J; Xu Y; Qin Z; Parsons C; Zhang B; Hu X; Wang L; Yu F; Pan J
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):373-6. PubMed ID: 23453788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.
    Loli A; Tzouvelekis LS; Tzelepi E; Carattoli A; Vatopoulos AC; Tassios PT; Miriagou V
    J Antimicrob Chemother; 2006 Sep; 58(3):669-72. PubMed ID: 16870645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.
    Kim SY; Park YJ; Yu JK; Kim HS; Park YS; Yoon JB; Yoo JY; Lee K
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):85-91. PubMed ID: 16854555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring bla(KPC) from New York City and Toronto.
    Mataseje LF; Boyd DA; Willey BM; Prayitno N; Kreiswirth N; Gelosia A; Poutanen SM; Low DE; Jenkins SG; Katz K; Mulvey MR
    J Antimicrob Chemother; 2011 Jun; 66(6):1273-7. PubMed ID: 21406433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
    Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
    Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae.
    Kubota H; Suzuki Y; Okuno R; Uchitani Y; Ariyoshi T; Takemura N; Mihara F; Mezaki K; Ohmagari N; Matsui M; Suzuki S; Sekizuka T; Kuroda M; Yokoyama K; Sadamasu K
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31666316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains.
    Evren E; Azap OK; Çolakoğlu Ş; Arslan H
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):335-8. PubMed ID: 23726147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.
    Bidet P; Burghoffer B; Gautier V; Brahimi N; Mariani-Kurkdjian P; El-Ghoneimi A; Bingen E; Arlet G
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3562-5. PubMed ID: 16048985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
    Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
    J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India.
    Roy S; Viswanathan R; Singh AK; Das P; Basu S
    J Antimicrob Chemother; 2011 Jun; 66(6):1411-3. PubMed ID: 21393155
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
    Leavitt A; Navon-Venezia S; Chmelnitsky I; Schwaber MJ; Carmeli Y
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3026-9. PubMed ID: 17562800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.